Aprepitant (aprepitant)
New formulation or manufacturer
- Region
- 🇺🇸 US
- Active substance
- aprepitant
- Company
- Azurity
- Status
- Approved
- FDA approval
- Tue 16 Jun 2026
- Designations
- New formulation or manufacturer
- Application
- NDA218754
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Tue 16 Jun 2026🇺🇸 FDA approval
FDA approves Aprepitant (aprepitant): new formulation or manufacturer
Azurity; NDA218754; New formulation or manufacturer; emulsion · source
Same substance in other markets
- 🇪🇺 Ivemend Authorised · Merck Sharp & Dohme B.V.
- 🇪🇺 Emend Authorised · Merck Sharp & Dohme B.V.
- 🇺🇸 Navitrux Approved · Avyxa Holdings
Follow Aprepitant
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.